Priority for Pediatric Cures Act
The source supplies the latest action, but no lifecycle stage.
Latest action (14 Sep 2026): Referred to the House Committee on Energy and Commerce.
What this bill does
This bill, titled the "Priority for Pediatric Cures Act," would amend the Federal Food, Drug, and Cosmetic Act. Specifically, it aims to permanently extend the authority of the Secretary of Health and Human Services to grant "priority review vouchers" for products intended to treat rare pediatric diseases.
These vouchers, when awarded, allow for expedited review of future drug applications. The bill affects companies developing treatments for rare diseases affecting children by making the voucher program permanent. It would not create new categories of diseases or require specific research outcomes, but rather modify the duration of an existing incentive program.
The bill was introduced in the House of Representatives on September 14, 2026, and was referred to the Committee on Energy and Commerce. As it has just been introduced, it will now proceed through the typical legislative process, which may include committee hearings and votes before potentially being considered by the full House and then the Senate.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
14 Sep 2026
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.R. 10359 do?
- This bill, titled the "Priority for Pediatric Cures Act," would amend the Federal Food, Drug, and Cosmetic Act. Specifically, it aims to permanently extend the authority of the Secretary of Health and Human Services to grant "priority review vouchers" for products intended to treat rare pediatric diseases. These vouchers, when awarded, allow for expedited review of future drug applications. The bill affects companies developing treatments for rare diseases affecting children by making the voucher program permanent. It would not create new categories of diseases or require specific research outcomes, but rather modify the duration of an existing incentive program. The bill was introduced in the House of Representatives on September 14, 2026, and was referred to the Committee on Energy and Commerce. As it has just been introduced, it will now proceed through the typical legislative process, which may include committee hearings and votes before potentially being considered by the full House and then the Senate.
- Has H.R. 10359 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10359. Check the latest action and official source below.
- Who sponsored H.R. 10359?
- H.R. 10359 was sponsored by Rep. Bilirakis, Gus M. [R-FL-12] (R-FL), with 9 cosponsors.
- What's the latest action on H.R. 10359?
- Referred to the House Committee on Energy and Commerce. (14 Sep 2026).
Related bills in Health
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Choices for Increased Mobility Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Bilirakis, Gus M. [R-FL-12]
Beagle Liberation Act of 2026
Part D Premium Protection Act of 2026
To obtain and direct the placement in the Capitol or on the Capitol Grounds of a statue to honor American humanitarian and star athlete Roberto Clemente of Puerto Rico.
Homeowners Premium Tax Reduction Act of 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.